Skip to main content
MedPathMedPath Home
Clinical Trials/CTRI/2019/07/020024
CTRI/2019/07/020024
Recruiting
Phase 1

Prospective Investigator Initiated Study to Evaluate the Biocompatibility and Indicative effectiveness of EndoArt in Subjects Having Corneal Edema with No Visual Potential - Not Applicable

Eye Yon Medical Ltd0 sites0 target enrollmentTBD
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit
ConditionsHealth Condition 1: H171- Central corneal opacityHealth Condition 2: null- Corneal Edema with No Visual Potential

Overview

Phase
Phase 1
Intervention
Not specified
Conditions
Health Condition 1: H171- Central corneal opacityHealth Condition 2: null- Corneal Edema with No Visual Potential
Sponsor
Eye Yon Medical Ltd
Status
Recruiting
Last Updated
4 years ago
OverviewInvestigatorsEligibility CriteriaOutcomesSimilar Trials

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
4 years ago
Study Type
Interventional

Investigators

Sponsor
Eye Yon Medical Ltd

Eligibility Criteria

Inclusion Criteria

  • •1\. Male Female Subject is over 50 years old
  • •2\. No Visual Potential
  • •3\. Clinical Corneal Edema
  • •4\. Corneal thickness \>650 μm
  • •5\. Subject understands the study requirements and the treatment procedures and provides written Informed Consent before any study\-specific tests or procedures are performed.
  • •6\. Pseudophakic subject (anterior or posterior) with stable IOL.

Exclusion Criteria

  • •1\. History of ocular Herpes keratitis
  • •2\. Subject with severely scarred cornea (unfit for regular endothelial keratoplasty)
  • •3\. Irregular posterior cornea (e.g. post PKP)
  • •4\. Active infection of the cornea
  • •5\. Band keratopathy and/or limbal stem cell deficiency.
  • •6\. Moderate to severe dry eye
  • •7\. Subject with phthisis or phthisis suspect
  • •8\. Very low ocular pressure \<\=6 mmHg or higher than 25 mmHg.
  • •9\. Aphakia or subluxated lens or pseudophacodonesis
  • •10\. Subject with glaucoma shunt (e.g. Ahmend valve)

Outcomes

Primary Outcomes

Not specified

Similar Trials

Active, not recruiting
Not Applicable
Study to see the Safety and Effectiveness of a custom made Porcine lens named as XeniaTM after implanting in patients having Keratoconus meaning Thin and Irregular cornea
CTRI/2021/04/033197Mr Steffen Gebauer5
Completed
Phase 1
A Phase 1 Investigator Initiated Study to Evaluate the Safety, Tolerability and Preliminary Effectiveness of AB-SA01 in Patients with Chronic Rhinosinusitis Associated with Staphylococcus aureus InfectioChronic rhinosinusitisInfection - Other infectious diseasesInflammatory and Immune System - Other inflammatory or immune system disorders
ACTRN12616000002482The Queen Elizabeth Hospital9
Not yet recruiting
Not Applicable
A Prospective Investigator-initiated Study to explore the optimal dose of lenalidomide in combination therapy for patients with Multiple Myeloma Featuring Renal Dysfunctio
KCT0009561The Catholic University of Korea, Seoul St. Mary's Hospital30
Completed
Not Applicable
Prospective Investigator Initiated Study to investigate Efficacy and Safety of cell-free Autologous Conditioned Serum (ACS) in reduced facial skin elasticity by womalack of facial skin elasticity by healthy volunteers
DRKS00009259niversität HamburgFachrichtung Kosmetikwissenschaft21
Terminated
Not Applicable
Triple therapy prevention of Recurrent Intracerebral Disease EveNts Trial (TRIDENT) Cognitive Sub-Study: Effectiveness of intensive long-term blood pressure lowering treatment, provided by a Triple Pill strategy, for slowing memory decline as measured by Cambridge Neuropsychological Test Automated Battery (CANTAB), in patients with a history of acute stroke due to intracerebral haemorrhage.
ACTRN12618001677291The George Institute1